The success of fecal microbial transplantation in Clostridium difficile infection correlates with bacteriophage relative abundance in the donor: a retrospective cohort study

Fecal microbial transplantation (FMT) is used in the treatment of relapsing Clostridium difficile infection (rCDI). Failure rate for FMT is as high as 10% but the mechanisms contributing to a failed FMT are not understood. We utilized metagenomic data to identify the role of bacteria and bacteriopha...

Full description

Saved in:
Bibliographic Details
Published inGut microbes Vol. 10; no. 6; pp. 676 - 687
Main Authors Park, Heekuk, Laffin, Michael R., Jovel, Juan, Millan, Braden, Hyun, Jae E., Hotte, Naomi, Kao, Dina, Madsen, Karen L.
Format Journal Article
LanguageEnglish
Published United States Taylor & Francis 02.11.2019
Subjects
Online AccessGet full text
ISSN1949-0976
1949-0984
1949-0984
DOI10.1080/19490976.2019.1586037

Cover

Abstract Fecal microbial transplantation (FMT) is used in the treatment of relapsing Clostridium difficile infection (rCDI). Failure rate for FMT is as high as 10% but the mechanisms contributing to a failed FMT are not understood. We utilized metagenomic data to identify the role of bacteria and bacteriophages on FMT success. Subjects with rCDI (n = 19) received FMT from volunteer donors (n = 7) via colonoscopy. Twelve patients fully recovered after a single FMT, while seven patients required a subsequent FMT. DNA was extracted from patient and donor stool samples for shotgun metagenomic analysis. Metagenomics libraries were analyzed focusing on bacterial taxonomy and bacteriophage sequences. Gammaproteobacteria were dominant in rCDI patients prior to FMT largely due to elevated levels of Klebsiella and Escherichia. A successful FMT led to increased levels of Clostridia and Bacteroidia and a reduction in Gammaproteobacteria. In contrast, a failed FMT led to no significant changes in bacterial composition. Bacteriophages were classified during whole metagenomic analysis of each sample and were markedly different between rCDI patients, donors, and a healthy control cohort (n = 96). Bacteriophage sequence reads were increased in CDI patients compared with donors and healthy controls. Successful FMT donors had higher bacteriophage α-diversity and lower relative abundance compared to the donors of a failed initial FMT. In this retrospective analysis, FMTs with increased bacteriophage α-diversity were more likely to successfully treat rCDI. In addition, the relative number of bacteriophage reads was lower in donations leading to a successful FMT. These results suggest that bacteriophage abundance may have some role in determining the relative success of FMT.
AbstractList Background: Fecal microbial transplantation (FMT) is used in the treatment of relapsing Clostridium difficile infection (rCDI). Failure rate for FMT is as high as 10% but the mechanisms contributing to a failed FMT are not understood. We utilized metagenomic data to identify the role of bacteria and bacteriophages on FMT success. Results: Subjects with rCDI (n = 19) received FMT from volunteer donors (n = 7) via colonoscopy. Twelve patients fully recovered after a single FMT, while seven patients required a subsequent FMT. DNA was extracted from patient and donor stool samples for shotgun metagenomic analysis. Metagenomics libraries were analyzed focusing on bacterial taxonomy and bacteriophage sequences. Gammaproteobacteria were dominant in rCDI patients prior to FMT largely due to elevated levels of Klebsiella and Escherichia. A successful FMT led to increased levels of Clostridia and Bacteroidia and a reduction in Gammaproteobacteria. In contrast, a failed FMT led to no significant changes in bacterial composition. Bacteriophages were classified during whole metagenomic analysis of each sample and were markedly different between rCDI patients, donors, and a healthy control cohort (n = 96). Bacteriophage sequence reads were increased in CDI patients compared with donors and healthy controls. Successful FMT donors had higher bacteriophage α-diversity and lower relative abundance compared to the donors of a failed initial FMT. Conclusions: In this retrospective analysis, FMTs with increased bacteriophage α-diversity were more likely to successfully treat rCDI. In addition, the relative number of bacteriophage reads was lower in donations leading to a successful FMT. These results suggest that bacteriophage abundance may have some role in determining the relative success of FMT.
Fecal microbial transplantation (FMT) is used in the treatment of relapsing Clostridium difficile infection (rCDI). Failure rate for FMT is as high as 10% but the mechanisms contributing to a failed FMT are not understood. We utilized metagenomic data to identify the role of bacteria and bacteriophages on FMT success. Subjects with rCDI (n = 19) received FMT from volunteer donors (n = 7) via colonoscopy. Twelve patients fully recovered after a single FMT, while seven patients required a subsequent FMT. DNA was extracted from patient and donor stool samples for shotgun metagenomic analysis. Metagenomics libraries were analyzed focusing on bacterial taxonomy and bacteriophage sequences. Gammaproteobacteria were dominant in rCDI patients prior to FMT largely due to elevated levels of Klebsiella and Escherichia. A successful FMT led to increased levels of Clostridia and Bacteroidia and a reduction in Gammaproteobacteria. In contrast, a failed FMT led to no significant changes in bacterial composition. Bacteriophages were classified during whole metagenomic analysis of each sample and were markedly different between rCDI patients, donors, and a healthy control cohort (n = 96). Bacteriophage sequence reads were increased in CDI patients compared with donors and healthy controls. Successful FMT donors had higher bacteriophage α-diversity and lower relative abundance compared to the donors of a failed initial FMT. In this retrospective analysis, FMTs with increased bacteriophage α-diversity were more likely to successfully treat rCDI. In addition, the relative number of bacteriophage reads was lower in donations leading to a successful FMT. These results suggest that bacteriophage abundance may have some role in determining the relative success of FMT.
Background: Fecal microbial transplantation (FMT) is used in the treatment of relapsing Clostridium difficile infection (rCDI). Failure rate for FMT is as high as 10% but the mechanisms contributing to a failed FMT are not understood. We utilized metagenomic data to identify the role of bacteria and bacteriophages on FMT success.Results: Subjects with rCDI (n = 19) received FMT from volunteer donors (n = 7) via colonoscopy. Twelve patients fully recovered after a single FMT, while seven patients required a subsequent FMT. DNA was extracted from patient and donor stool samples for shotgun metagenomic analysis. Metagenomics libraries were analyzed focusing on bacterial taxonomy and bacteriophage sequences. Gammaproteobacteria were dominant in rCDI patients prior to FMT largely due to elevated levels of Klebsiella and Escherichia. A successful FMT led to increased levels of Clostridia and Bacteroidia and a reduction in Gammaproteobacteria. In contrast, a failed FMT led to no significant changes in bacterial composition. Bacteriophages were classified during whole metagenomic analysis of each sample and were markedly different between rCDI patients, donors, and a healthy control cohort (n = 96). Bacteriophage sequence reads were increased in CDI patients compared with donors and healthy controls. Successful FMT donors had higher bacteriophage α-diversity and lower relative abundance compared to the donors of a failed initial FMT.Conclusions: In this retrospective analysis, FMTs with increased bacteriophage α-diversity were more likely to successfully treat rCDI. In addition, the relative number of bacteriophage reads was lower in donations leading to a successful FMT. These results suggest that bacteriophage abundance may have some role in determining the relative success of FMT.Background: Fecal microbial transplantation (FMT) is used in the treatment of relapsing Clostridium difficile infection (rCDI). Failure rate for FMT is as high as 10% but the mechanisms contributing to a failed FMT are not understood. We utilized metagenomic data to identify the role of bacteria and bacteriophages on FMT success.Results: Subjects with rCDI (n = 19) received FMT from volunteer donors (n = 7) via colonoscopy. Twelve patients fully recovered after a single FMT, while seven patients required a subsequent FMT. DNA was extracted from patient and donor stool samples for shotgun metagenomic analysis. Metagenomics libraries were analyzed focusing on bacterial taxonomy and bacteriophage sequences. Gammaproteobacteria were dominant in rCDI patients prior to FMT largely due to elevated levels of Klebsiella and Escherichia. A successful FMT led to increased levels of Clostridia and Bacteroidia and a reduction in Gammaproteobacteria. In contrast, a failed FMT led to no significant changes in bacterial composition. Bacteriophages were classified during whole metagenomic analysis of each sample and were markedly different between rCDI patients, donors, and a healthy control cohort (n = 96). Bacteriophage sequence reads were increased in CDI patients compared with donors and healthy controls. Successful FMT donors had higher bacteriophage α-diversity and lower relative abundance compared to the donors of a failed initial FMT.Conclusions: In this retrospective analysis, FMTs with increased bacteriophage α-diversity were more likely to successfully treat rCDI. In addition, the relative number of bacteriophage reads was lower in donations leading to a successful FMT. These results suggest that bacteriophage abundance may have some role in determining the relative success of FMT.
: Fecal microbial transplantation (FMT) is used in the treatment of relapsing infection (rCDI). Failure rate for FMT is as high as 10% but the mechanisms contributing to a failed FMT are not understood. We utilized metagenomic data to identify the role of bacteria and bacteriophages on FMT success. : Subjects with rCDI (n = 19) received FMT from volunteer donors (n = 7) via colonoscopy. Twelve patients fully recovered after a single FMT, while seven patients required a subsequent FMT. DNA was extracted from patient and donor stool samples for shotgun metagenomic analysis. Metagenomics libraries were analyzed focusing on bacterial taxonomy and bacteriophage sequences. Gammaproteobacteria were dominant in rCDI patients prior to FMT largely due to elevated levels of and . A successful FMT led to increased levels of Clostridia and Bacteroidia and a reduction in Gammaproteobacteria. In contrast, a failed FMT led to no significant changes in bacterial composition. Bacteriophages were classified during whole metagenomic analysis of each sample and were markedly different between rCDI patients, donors, and a healthy control cohort (n = 96). Bacteriophage sequence reads were increased in CDI patients compared with donors and healthy controls. Successful FMT donors had higher bacteriophage α-diversity and lower relative abundance compared to the donors of a failed initial FMT. : In this retrospective analysis, FMTs with increased bacteriophage α-diversity were more likely to successfully treat rCDI. In addition, the relative number of bacteriophage reads was lower in donations leading to a successful FMT. These results suggest that bacteriophage abundance may have some role in determining the relative success of FMT.
Author Hotte, Naomi
Millan, Braden
Laffin, Michael R.
Madsen, Karen L.
Park, Heekuk
Jovel, Juan
Hyun, Jae E.
Kao, Dina
Author_xml – sequence: 1
  givenname: Heekuk
  orcidid: 0000-0001-5815-9717
  surname: Park
  fullname: Park, Heekuk
  organization: Center of Excellence for Gastrointestinal Inflammation and Immunity Research
– sequence: 2
  givenname: Michael R.
  surname: Laffin
  fullname: Laffin, Michael R.
  organization: University of Alberta
– sequence: 3
  givenname: Juan
  surname: Jovel
  fullname: Jovel, Juan
  organization: Center of Excellence for Gastrointestinal Inflammation and Immunity Research
– sequence: 4
  givenname: Braden
  surname: Millan
  fullname: Millan, Braden
  organization: Center of Excellence for Gastrointestinal Inflammation and Immunity Research
– sequence: 5
  givenname: Jae E.
  surname: Hyun
  fullname: Hyun, Jae E.
  organization: Center of Excellence for Gastrointestinal Inflammation and Immunity Research
– sequence: 6
  givenname: Naomi
  surname: Hotte
  fullname: Hotte, Naomi
  organization: Center of Excellence for Gastrointestinal Inflammation and Immunity Research
– sequence: 7
  givenname: Dina
  orcidid: 0000-0002-6096-0586
  surname: Kao
  fullname: Kao, Dina
  organization: Center of Excellence for Gastrointestinal Inflammation and Immunity Research
– sequence: 8
  givenname: Karen L.
  orcidid: 0000-0002-8636-0714
  surname: Madsen
  fullname: Madsen, Karen L.
  email: Karen.madsen@ualberta.ca
  organization: Center of Excellence for Gastrointestinal Inflammation and Immunity Research
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30866714$$D View this record in MEDLINE/PubMed
BookMark eNqNkstu1DAUhiNUREvpI4C8ZDODnYvjgIRAI25SJTZlbZ340hg5drCdjuaheEecZlouC8AbWz7__x_bnx8XJ847VRRPCd4SzPAL0tUd7lq6LTHptqRhFFftg-Js2d_gjtUn9-uWnhYXMX7FedR1i2n1qDitMKO0JfVZ8f1qUCjOQqgYkddIKwEWjUYE35u8SgFcnCy4BMl4h4xDO-tjCkaaeUTSaG2EsSoXsvVWInwIykJSEe1NGlAPIqlg_DTAtUK3JXOjEPSzk-DEYkUpn0J658NLBFmSgo_TEpd1wg8-JBTTLA9PiocabFQXx_m8-PL-3dXu4-by84dPu7eXG1FTljayBoASN50uNW1Z2euWEQoU675r61Y3LS5ZL7O4lIQwxWRV1Q3IvillpytRnRd0zZ3dBIc9WMunYEYIB04wXxDwOwR8QcCPCLLx9Wqc5n5UUiiXH_Cn2YPhv1ecGfi1v-GUZR6szAHPjwHBf5tVTHw0USibCSg_R16SjlSUYLJIn_3a677JHdwsaFZBhhljUPq_L_HqD58wK_58ZGP_6X6zuvOP8GGEvQ9W8gQH64POv0mYyKu_R_wA-67j7g
CitedBy_id crossref_primary_10_1016_j_eclinm_2020_100642
crossref_primary_10_3389_fcimb_2021_755650
crossref_primary_10_3390_nu13031018
crossref_primary_10_1038_s41575_021_00441_5
crossref_primary_10_1038_s41575_022_00610_0
crossref_primary_10_1128_aem_02265_24
crossref_primary_10_1016_j_copbio_2020_09_016
crossref_primary_10_3390_microorganisms11051181
crossref_primary_10_1016_j_csbj_2022_01_009
crossref_primary_10_5812_jjm_129130
crossref_primary_10_1051_medsci_2022169
crossref_primary_10_1016_j_cmi_2023_01_018
crossref_primary_10_1016_j_jad_2024_03_088
crossref_primary_10_2147_JIR_S338212
crossref_primary_10_1016_j_micres_2021_126942
crossref_primary_10_3389_fcimb_2021_822562
crossref_primary_10_1093_femsec_fiad068
crossref_primary_10_1136_gutjnl_2019_320005
crossref_primary_10_3389_fmicb_2025_1556827
crossref_primary_10_1016_j_cmi_2022_11_012
crossref_primary_10_1016_j_mib_2020_05_008
crossref_primary_10_1016_S2468_1253_21_00303_4
crossref_primary_10_1080_1061186X_2023_2299724
crossref_primary_10_3389_fcimb_2021_643214
crossref_primary_10_1111_apt_15557
crossref_primary_10_1093_bioinformatics_btad236
crossref_primary_10_1016_j_lfs_2022_120719
crossref_primary_10_1016_j_coviro_2019_06_003
crossref_primary_10_1080_19490976_2020_1810531
crossref_primary_10_1007_s10620_020_06676_7
crossref_primary_10_1038_s41390_019_0491_8
crossref_primary_10_48022_mbl_2212_12002
crossref_primary_10_1007_s12016_023_08958_0
crossref_primary_10_1038_s41575_020_0350_4
crossref_primary_10_1002_jpen_2333
crossref_primary_10_1053_j_gastro_2020_09_057
Cites_doi 10.1101/gr.122705.111
10.1086/315239
10.1053/j.gastro.2014.07.020
10.1126/science.1177486
10.1046/j.1365-2958.1998.00947.x
10.1128/mBio.00260-11
10.1101/gr.138297.112
10.1053/j.gastro.2016.11.010
10.1128/mSystems.00127-16
10.1128/JB.188.7.2726-2729.2006
10.7326/M14-2693
10.1038/nature12212
10.1007/s11908-017-0586-5
10.4161/gmic.22371
10.1136/gutjnl-2017-313952
10.1073/pnas.1601060113
10.1126/science.1165771
10.1016/S1473-3099(05)70215-2
10.1038/nrgastro.2016.98
10.1016/j.vetmic.2007.11.032
10.1016/0027-5107(92)90106-C
10.1016/j.cgh.2011.08.014
10.1002/cpt.747
10.1086/525047
10.1186/gb-2014-15-3-r46
10.1093/bioinformatics/btu616
10.1016/j.coviro.2011.06.009
10.1016/j.bbrc.2015.12.083
10.1128/mBio.00322-16
10.1001/jama.2017.17077
10.1080/19490976.2016.1278105
10.1186/2049-2618-2-13
10.1126/science.1159689
10.1016/j.cell.2012.10.052
10.1016/j.tim.2014.02.010
10.1097/MCG.0000000000000374
10.1371/journal.pone.0000799
10.3389/fmicb.2018.00749
10.3748/wjg.v21.i17.5359
10.1038/msb.2013.22
10.1038/nature09199
10.1038/ismej.2014.30
10.1073/pnas.1300833110
10.1097/MCG.0000000000000410
10.1097/MCG.0b013e3181c87e02
ContentType Journal Article
Copyright 2019 Taylor & Francis Group, LLC 2019
2019 Taylor & Francis Group, LLC 2019 Taylor & Francis
Copyright_xml – notice: 2019 Taylor & Francis Group, LLC 2019
– notice: 2019 Taylor & Francis Group, LLC 2019 Taylor & Francis
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ADTOC
UNPAY
DOI 10.1080/19490976.2019.1586037
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Unpaywall for CDI: Periodical Content
Unpaywall
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate H. PARK ET AL
EISSN 1949-0984
EndPage 687
ExternalDocumentID 10.1080/19490976.2019.1586037
PMC6867182
30866714
10_1080_19490976_2019_1586037
1586037
Genre Research Article
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: CIHR
– fundername: ;
– fundername: ; ;
GroupedDBID ---
00X
0YH
30N
4.4
53G
ABPEM
ACGFS
ACTIO
ADBBV
ADCVX
AEISY
AGYJP
AIJEM
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AQRUH
BABNJ
BAWUL
BLEHA
CCCUG
DGEBU
DIK
DKSSO
EBS
EMOBN
F5P
GROUPED_DOAJ
H13
HYE
IPNFZ
KYCEM
LJTGL
M4Z
MM.
O9-
OK1
RIG
RPM
SNACF
SV3
TDBHL
TFL
TFT
TFW
TR2
TTHFI
AAYXX
AIYEW
CITATION
ABCCY
C1A
CGR
CUY
CVF
ECM
EIF
EJD
NPM
OVD
TEORI
7X8
5PM
ADTOC
UNPAY
ID FETCH-LOGICAL-c468t-d4aaa2059f2f6782bf7816a60fb9747f57028bdc462d118e8d3345adb52d9f3c3
ISSN 1949-0976
1949-0984
IngestDate Tue Aug 19 20:46:36 EDT 2025
Tue Sep 30 16:49:34 EDT 2025
Fri Jul 11 13:05:09 EDT 2025
Thu Apr 03 07:05:35 EDT 2025
Thu Apr 24 22:55:24 EDT 2025
Tue Jul 01 03:30:36 EDT 2025
Wed Dec 25 09:08:12 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords FMT
Clostridium difficile infection
intestinal microbiome
bacteriophages
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c468t-d4aaa2059f2f6782bf7816a60fb9747f57028bdc462d118e8d3345adb52d9f3c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Present address: Braden Millan, Cumming School of Medicine, University of Calgary, Calgary, Alberta
ORCID 0000-0002-6096-0586
0000-0002-8636-0714
0000-0001-5815-9717
OpenAccessLink https://www.tandfonline.com/doi/pdf/10.1080/19490976.2019.1586037?needAccess=true
PMID 30866714
PQID 2191361012
PQPubID 23479
PageCount 12
ParticipantIDs crossref_primary_10_1080_19490976_2019_1586037
pubmed_primary_30866714
proquest_miscellaneous_2191361012
unpaywall_primary_10_1080_19490976_2019_1586037
crossref_citationtrail_10_1080_19490976_2019_1586037
informaworld_taylorfrancis_310_1080_19490976_2019_1586037
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6867182
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-11-02
PublicationDateYYYYMMDD 2019-11-02
PublicationDate_xml – month: 11
  year: 2019
  text: 2019-11-02
  day: 02
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Gut microbes
PublicationTitleAlternate Gut Microbes
PublicationYear 2019
Publisher Taylor & Francis
Publisher_xml – name: Taylor & Francis
References cit0011
cit0033
cit0012
cit0034
cit0031
cit0010
cit0032
cit0030
cit0019
cit0017
cit0039
cit0018
cit0015
cit0037
cit0016
cit0038
cit0013
cit0035
cit0014
cit0036
cit0022
cit0044
cit0001
cit0023
cit0045
cit0020
cit0042
cit0021
cit0043
cit0040
cit0041
cit0008
cit0009
cit0006
cit0028
cit0007
cit0029
cit0004
cit0026
cit0005
cit0027
cit0002
cit0024
cit0003
cit0025
References_xml – ident: cit0018
  doi: 10.1101/gr.122705.111
– ident: cit0022
  doi: 10.1086/315239
– ident: cit0030
  doi: 10.1053/j.gastro.2014.07.020
– ident: cit0037
  doi: 10.1126/science.1177486
– ident: cit0020
  doi: 10.1046/j.1365-2958.1998.00947.x
– ident: cit0033
  doi: 10.1128/mBio.00260-11
– ident: cit0017
  doi: 10.1101/gr.138297.112
– ident: cit0014
  doi: 10.1053/j.gastro.2016.11.010
– ident: cit0044
  doi: 10.1128/mSystems.00127-16
– ident: cit0021
  doi: 10.1128/JB.188.7.2726-2729.2006
– ident: cit0026
  doi: 10.7326/M14-2693
– ident: cit0036
  doi: 10.1038/nature12212
– ident: cit0006
  doi: 10.1007/s11908-017-0586-5
– ident: cit0010
  doi: 10.4161/gmic.22371
– ident: cit0015
  doi: 10.1136/gutjnl-2017-313952
– ident: cit0013
  doi: 10.1073/pnas.1601060113
– ident: cit0041
  doi: 10.1126/science.1165771
– ident: cit0001
  doi: 10.1016/S1473-3099(05)70215-2
– ident: cit0029
  doi: 10.1038/nrgastro.2016.98
– ident: cit0023
  doi: 10.1016/j.vetmic.2007.11.032
– ident: cit0035
  doi: 10.1016/0027-5107(92)90106-C
– ident: cit0002
  doi: 10.1016/j.cgh.2011.08.014
– ident: cit0007
  doi: 10.1002/cpt.747
– ident: cit0031
  doi: 10.1086/525047
– ident: cit0043
  doi: 10.1186/gb-2014-15-3-r46
– ident: cit0045
  doi: 10.1093/bioinformatics/btu616
– ident: cit0039
  doi: 10.1016/j.coviro.2011.06.009
– ident: cit0024
  doi: 10.1016/j.bbrc.2015.12.083
– ident: cit0011
  doi: 10.1128/mBio.00322-16
– ident: cit0042
  doi: 10.1001/jama.2017.17077
– ident: cit0008
  doi: 10.1080/19490976.2016.1278105
– ident: cit0028
  doi: 10.1186/2049-2618-2-13
– ident: cit0040
  doi: 10.1126/science.1159689
– ident: cit0032
  doi: 10.1016/j.cell.2012.10.052
– ident: cit0009
  doi: 10.1016/j.tim.2014.02.010
– ident: cit0005
  doi: 10.1097/MCG.0000000000000374
– ident: cit0034
  doi: 10.1371/journal.pone.0000799
– ident: cit0038
  doi: 10.3389/fmicb.2018.00749
– ident: cit0003
  doi: 10.3748/wjg.v21.i17.5359
– ident: cit0025
  doi: 10.1038/msb.2013.22
– ident: cit0012
  doi: 10.1038/nature09199
– ident: cit0019
  doi: 10.1038/ismej.2014.30
– ident: cit0016
  doi: 10.1073/pnas.1300833110
– ident: cit0004
  doi: 10.1097/MCG.0000000000000410
– ident: cit0027
  doi: 10.1097/MCG.0b013e3181c87e02
SSID ssj0000447063
Score 2.3943105
Snippet Fecal microbial transplantation (FMT) is used in the treatment of relapsing Clostridium difficile infection (rCDI). Failure rate for FMT is as high as 10% but...
: Fecal microbial transplantation (FMT) is used in the treatment of relapsing infection (rCDI). Failure rate for FMT is as high as 10% but the mechanisms...
Background: Fecal microbial transplantation (FMT) is used in the treatment of relapsing Clostridium difficile infection (rCDI). Failure rate for FMT is as high...
SourceID unpaywall
pubmedcentral
proquest
pubmed
crossref
informaworld
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 676
SubjectTerms Adult
Aged
Aged, 80 and over
Bacteria - classification
Bacteria - genetics
Bacteria - isolation & purification
bacteriophages
Bacteriophages - classification
Bacteriophages - genetics
Clostridium difficile - physiology
Clostridium difficile infection
Clostridium Infections - microbiology
Clostridium Infections - therapy
Clostridium Infections - virology
Cohort Studies
Fecal Microbiota Transplantation
Feces - microbiology
Feces - virology
Female
FMT
Gastrointestinal Microbiome - genetics
Humans
intestinal microbiome
Male
Middle Aged
Recurrence
Research Paper/Report
Retrospective Studies
Tissue Donors
Treatment Outcome
Title The success of fecal microbial transplantation in Clostridium difficile infection correlates with bacteriophage relative abundance in the donor: a retrospective cohort study
URI https://www.tandfonline.com/doi/abs/10.1080/19490976.2019.1586037
https://www.ncbi.nlm.nih.gov/pubmed/30866714
https://www.proquest.com/docview/2191361012
https://pubmed.ncbi.nlm.nih.gov/PMC6867182
https://www.tandfonline.com/doi/pdf/10.1080/19490976.2019.1586037?needAccess=true
UnpaywallVersion publishedVersion
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1949-0984
  dateEnd: 20241001
  omitProxy: true
  ssIdentifier: ssj0000447063
  issn: 1949-0976
  databaseCode: DIK
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 1949-0984
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000447063
  issn: 1949-0976
  databaseCode: RPM
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVAWR
  databaseName: Taylor & Francis Science and Technology Library-DRAA
  customDbUrl:
  eissn: 1949-0984
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000447063
  issn: 1949-0976
  databaseCode: 30N
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: http://www.tandfonline.com/page/title-lists
  providerName: Taylor & Francis
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db5swFLWiTtv6Mu172Zc8aW8RKQFiYG9TtS2qtqqaUqlvyICtRk0gSqFT95_2z_Yjdq9tDLSR2vUFJQSD4R7b95Jz7iXkYzRNQxGmriPdUDqBkLmTskg4WQbDT7qCe1wRZA_Z7Dg4OJmeDAZ_O6ylukrH2e-tupK7WBX2gV1RJfsflrUnhR3wGewLW7AwbG9t4_NalTxEp08KfOCrhcqtpEjkmLh8yQvDKESB37LEQh35ol6p2iiLDGYFy8hCSvpGqVuEUb2lOplzuT5Fbo8WvlyIEU9RQIJzgqFJ5mVRbrRweiOqTdkIOEdYgHdTdbLYGkf4W12ZnrYkxiPD254JcVZbBdF3Dt3sUvxHP8ct7-dCswwO6hblKG_Ur3WRKGCkbubFxiRWCr82DJ5fqzHSmabjAIleoUmi3d2nC87Zud3tYLg7UbOmrf6mF_1ry4nmX-KZ8WJIBIzHk2nEXL93PDze9UphzIcIkYVaFnslj_fRj32GyQQjcBjueSFjWG_Ddw_tG0E3CEJd-s_eXiM5i9y9rZ3YJQ-aK_b8ql7W3W2x03UK8MO6WPPLX3y57PhX88fkkQmM6GeN8idkIIqn5L4ulXr5jPwBrFODdVpKqrBOLdbpFazTRUE7WKcW69RinbZYp4h12sM6bbBOLdbxnIB1qrD-iXLaQzrVSKcK6c_J8dcv8_2ZY0qNOFnAosrJA865B6GG9CS4b14qw2jCOHNligG3nIbgh6c5HOzlEJKLKPf9YMrzdOrlsfQz_wXZKcpCvCI049zPcOHMJZjMy1OIIWLuRkEsGQb8QxI0hkoyk4cfy8Esk4lJ19uYOkFTJ8bUQzK2zdY6Ec1NDeIuCpJKjSeph1Li39D2QwOZBJYb_A-RF6KszxNwcCY-w6SAQ_JSQ8h2p4HikIQ9cNkDMJV9_5dicapS2puRMSR7Foa3u8vXd77WG7LbzjpvyU61qcU7CDCq9L0al_8AcHEn6Q
linkProvider Taylor & Francis
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Zb9QwELagCJUX7mM5jcRrtjmdhDdUUS1Q9qmV-hb5VKOmzmqbgMp_4j8yYyfRLoeK1LdI8VhxPJnDmfk-Qt4Vmch1LsLAhLkJUm1UIFihAynh8zOh5jF3BbJLtjhOP59kJxu9MFhWiTm08UARzlbjx42H0WNJ3B4k3mUIfhQrs8p5lBUsTPKb5FaGSCPYxhEup3OWME1zT6iGUgGKjY08_5ppy0VtAZj-LQz9s5pyt7crfvmdN82Gqzq4R-S4SF-hcjbvOzGXP37Df7zeW7hP7g6RLP3gVe8BuaHtQ3Lbc1tePiI_QQHpRe_4GGlrqNGgDfS8dsBPcNU5VPWG-9YnS2tL95sWWURU3Z9TJG6pJZgsOpaLWSqRSaTB4Jji8TEVHmm6XZ2CUaS-K-ebplxgdwsoM84J8S1VrW3X7ymHId26HXtLKXIDrzvqAHYfk-ODj0f7i2DghghkyoouUCnnPIbY0MQG_G0sTF5EjLPQCMyQTJZD4CQUDI4V5FC6UEmSZlyJLFalSWTyhOzY1upnhErOE4mWThl4o7ESEPSVPCzS0jDM0GYkHdWhkgNwOvJ3NFU04KuOO1HhTlTDTszIfBJbeeSQqwTKTV2rOndkYzy_SpVcIft2VMwK7AP-9OFWt_1FBR4pShiiuM3IU6-o0-MkkM-yPEpnJN9S4WkAYo9v37H1qcMgZ4iLWMCce5Oy_98qn19jlW_I7uLo62F1-Gn55QW5g7dcW2j8kux0616_gviwE6-dAfgF7r9aBA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Zb9QwELagiOOFs8ByGonXbHM4TsIbKqzKoRUPVOItsmNbjUid1W7Sqvwn_iMzdhJ1OVSkvq0Uj7WOx3M4M99HyOs8lZnOZBiYMDMB00YFkuc6qCo4fibUIhauQHbJDw7Zx2_pWE24GcoqMYc2HijC2Wo83Ctlxoq4Pci7ixDcKBZmFfMozXmYZFfJNY59ptjFES6na5aQsczzqaFUgGJjH8-_ZtryUFv4pX-LQv8sprzZ25U4OxVNc85TLe4QOa7RF6h8n_ednFc_foN_vNRLuEtuD3EsfesV7x65ou19ct0zW549ID9B_eimd2yMtDXUaNAFelw72Cf41TlM9Ub4xidLa0v3mxY5RFTdH1OkbakrMFh0LBaztEIekQZDY4qXx1R6nOl2dQQmkfqenBNNhcTeFlBlnBOiW6pa267fUAFDunU7dpZSZAZed9TB6-6Sw8X7r_sHwcAMEVSM512gmBAihsjQxAa8bSxNlkdc8NBIzI9MmkHYJBUMjhVkUDpXScJSoWQaq8IkVfKQ7NjW6seEVkIkFdo5ZeCNxkpCyFeIMGeF4ZifzQgbtaGsBth0ZO9oymhAVx13osSdKIedmJH5JLbyuCEXCRTnVa3s3IWN8ewqZXKB7KtRL0uwDvjJR1jd9psS_FGUcMRwm5FHXk-nv5NANsuziM1ItqXB0wBEHt9-Yusjh0DOERUxhzn3Jl3_v1U-ucQqX5IbX94tys8flp-eklv4xPWExs_ITrfu9XMIDjv5wh3_X4j8WLE
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+success+of+fecal+microbial+transplantation+in+Clostridium+difficile+infection+correlates+with+bacteriophage+relative+abundance+in+the+donor%3A+a+retrospective+cohort+study&rft.jtitle=Gut+microbes&rft.au=Park%2C+Heekuk&rft.au=Laffin%2C+Michael+R.&rft.au=Jovel%2C+Juan&rft.au=Millan%2C+Braden&rft.date=2019-11-02&rft.pub=Taylor+%26+Francis&rft.issn=1949-0976&rft.eissn=1949-0984&rft.volume=10&rft.issue=6&rft.spage=676&rft.epage=687&rft_id=info:doi/10.1080%2F19490976.2019.1586037&rft_id=info%3Apmid%2F30866714&rft.externalDocID=PMC6867182
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1949-0976&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1949-0976&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1949-0976&client=summon